Surprise! Last-Minute 2025 Reimbursement Changes
Summary: March 2026 article outlines unanticipated late-2025 Medicare reimbursement changes affecting wound care providers. Key updates: LCD revisions (e.g., stricter medical necessity for biologics/skin substitutes, vascular assessment timelines), HCPCS code adjustments (G0465 blood-derived products under review), documentation burdens (e.g., photo proof, longitudinal notes), and MAC-specific policies causing denials spikes. Impacts: Increased administrative load, cash flow disruptions, potential service reductions. Strategies: Proactive audits, template updates, payer education, advocacy via societies. Emphasizes preparation for 2026 PFS rules; warns of cascading effects on advanced therapies (synthetics, NPWT, grafts). Ties to broader policy shifts and provider resilience.
Key Highlights:
- Changes: LCD/HCPCS tweaks, documentation rigor.
- Effects: Denials, revenue risks.
- Solutions: Audits, templates, advocacy.
- Relevance: Critical for sustaining synthetic/innovative care amid policy flux.
Read full article (subscription may be required)
Keywords: 2025 reimbursement changes, Medicare LCD, wound care denials, compliance strategies